S. Robinson et al., DYSLIPIDEMIA IS ASSOCIATED WITH INSULIN-RESISTANCE IN WOMEN WITH POLYCYSTIC OVARIES, Clinical endocrinology, 44(3), 1996, pp. 277-284
OBJECTIVE Polycystic ovary syndrome (PCOS) is characterized by hyperin
sulinaemia and insulin resistance. Previous reports of lipid abnormali
ties in the syndrome have produced conflicting results which may, in p
art, be related to the lack of appropriate controls for the obese wome
n with PCOS. Only one study has related lipid levels to insulin sensit
ivity. The objective of this study was to assess lipids and lipoprotei
ns in women with PCOS, to compare the results with weight matched cont
rols, and to relate the findings to indices of insulin secretion and a
ction, and to menstrual history. DESIGN A cross-sectional study of ins
ulin sensitivity and lipids in a cohort of PCO subjects compared to we
ight and ethnic group matched controls. PATIENTS AND METHODS We have t
herefore investigated glucose tolerance, plasma lipids and lipoprotein
s In 19 lean (LP) and 55 obese (OF) patients with PCO and compared the
results with those in 22 lean (LC) and 15 obese (OC) control women. I
nsulin sensitivity was measured in the same subjects with a short insu
lin (0.05 U/kg i.v. insulin) tolerance test (LP, n = 18; OP, n = 20; L
C, n = 19; OC, n = 11). RESULTS Results are expressed as mean+/-SEM or
median (interquartile range). Pasting plasma glucose levels were simi
lar in the four groups but the plasma glucose area was higher after or
al glucose (75 g) in both the lean and obese PCOS groups than in their
controls (LC 32.4 +/- 0.7 vs LP 35.2 +/- 1.2, P < 0.01; OC 34.7 +/- 1
.8 vs OP 37.8 +/- 1.5 mmol/l/3 h, P < 0.01). Insulin sensitivity was s
ignificantly reduced in obese PCOS women (LC 196 +/- 9 vs LP 179 +/- 9
, NS; OC 168 +/- 12 vs OP 133 +/- 9 mmol/l/min, P < 0.01). Total serum
cholesterol levels were similar in the lour groups but HDL(2)-cholest
erol was reduced in both obese and lean PCOS (LC 0.42 (0.38-0.62), LP
0.31 (0.26-0.44), P < 0.05; OC 0.34 (0.21-0.47), OP 0.21 (0.12-0.32)mm
ol/l, P < 0.01). Total HDL-cholesterol was decreased significantly onl
y in the obese PCOS group. Body mass index correlated significantly an
d negatively with total HDL-cholesterol and with HDL-cholesterol level
s both within the PCOS group and the control women. Using multiple reg
ression insulin insensitivity contributes significantly beyond BMI to
the low HDL-cholesterol in women with polycystic ovaries. CONCLUSION P
olycystic ovary syndrome is associated with biochemical risk factors f
or premature vascular disease, which cannot be explained by obesity al
one.